Business ❯ Pharmaceutical Industry

Drug Pricing

Market Competition Market Access Market Trends Market Dynamics Market Regulation Market Launch Market Strategies Insurance Coverage Market Impact Market Strategy

Senate Finance Advances Klomp Nomination to Be HHS Deputy

The committee vote sends the nomination to the full Senate and raises urgent questions about oversight of secretive drug‑pricing agreements.

Florida Sues Insulin Makers, PBMs and Rebate Firms Over Alleged Price-Inflation Scheme

FDA Approves Fayuvi, Ultragenyx’s $3.95 Million One‑Time Gene Therapy for Sanfilippo A

FDA Approves Lisraya as First Oral Treatment for Adult Dermatomyositis

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma mRNA Vaccine

UK Regulator Approves Eli Lilly’s Foundayo Tablet for Weight Loss and Type 2 Diabetes

Eli Lilly Opens Limited Early Access to Experimental Obesity Drug Retatrutide

Michigan Supreme Court Restores Probe of Eli Lilly Insulin Pricing

G-BA Chair Says Reconsideration of GLP‑1 Weight Injections for Insurance Coverage Is Worth Considering

Novo Nordisk Cuts Ozempic Price for Uninsured Canadians as Generics Hit Shelves

Generic Semaglutide Hits Canadian Pharmacy Shelves

Roche Launches 7-Minute Under-the-Skin Lung Cancer Shot in India

Lilly Launches First Amyloid-Targeting Alzheimer’s Drug in India at Rs 91,688 a Dose

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

Health Canada Approves Apotex’s Generic Ozempic, Opening Canada’s Market to Lower-Cost Semaglutide

FDA Approves First Gene Therapy for Inherited Hearing Loss

Trump Seals Regeneron Drug-Pricing Pact, Completing 17-Company Push

Dosing Disputes, Counterfeits, and a Patent Wall Put Keytruda Under Fresh Scrutiny

FDA Approves Filspari to Reduce Proteinuria in FSGS Patients Without Nephrotic Syndrome

Counterfeit Keytruda Reached Mexico’s Public Hospitals, New Forensic Findings and Procurement Data Reveal